Novasep‐PharmaZell invests €7.3M

Novasep‐PharmaZell invests €7.3M to increase API production capacity at Mourenx site

• With support from the French government “France Relance” Plan, this €7.3M investment allows the Group to expand ongoing efforts to modernize equipment and increase production capacity at its site in Mourenx
• The initial priority will be to create a new pilot workshop for API production
• This workshop will be operational in Q2 2023 and be focused on handling innovative and highly active products including cancer treatments

Read the press release